rab3c Gene

rab3c Gene

Introduction

Rab3C Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-gene"> [@fukuda2008]

| Attribute | Value | [@geppert1994]
|-----------|-------| [@ting2012]
| Gene Symbol | RAB3C | [^5]
| Full Name | RAB3C, Member RAS Oncogene Family |
| Chromosomal Location | 22q12.3 |
| NCBI Gene ID | [54715](https://www.ncbi.nlm.nih.gov/gene/54715) |
| Ensembl ID | ENSG00000172985 |
| UniProt ID | [Q8WV99](https://www.uniprot.org/uniprot/Q8WV99) |
| OMIM ID | - |
| Gene Family | Rab GTPase family |

</div>}

Overview

rab3c Gene

Introduction

Rab3C Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-gene"> [@fukuda2008]

| Attribute | Value | [@geppert1994]
|-----------|-------| [@ting2012]
| Gene Symbol | RAB3C | [^5]
| Full Name | RAB3C, Member RAS Oncogene Family |
| Chromosomal Location | 22q12.3 |
| NCBI Gene ID | [54715](https://www.ncbi.nlm.nih.gov/gene/54715) |
| Ensembl ID | ENSG00000172985 |
| UniProt ID | [Q8WV99](https://www.uniprot.org/uniprot/Q8WV99) |
| OMIM ID | - |
| Gene Family | Rab GTPase family |

</div>}

Overview

The RAB3C (RAB3C, Member RAS Oncogene Family) gene encodes a member of the Rab GTPase family, which is part of the Ras superfamily of small GTPases. RAB3C is primarily expressed in neuronal and neuroendocrine tissues, where it plays essential roles in regulated secretion, synaptic vesicle trafficking, and neurotransmitter release. Like other Rab3 isoforms (RAB3A, RAB3B, RAB3D), RAB3C is crucial for maintaining synaptic plasticity and neuronal communication.

The Rab GTPase family comprises over 60 members in humans, each functioning as molecular switches that cycle between an active GTP-bound state and an inactive GDP-bound state. This cycling is tightly regulated by guanine nucleotide exchange factors (GEFs) that promote GTP loading, and GTPase-activating proteins (GAPs) that accelerate GTP hydrolysis. RAB3C, like other neuronal Rab3 isoforms, is specifically adapted for the unique demands of regulated secretion in [neurons](/entities/neurons) and neuroendocrine cells.

Gene Structure

Genomic Organization

• Chromosome: 22
• Location: 22q12.3
• Exons: Multiple exons spanning approximately 20 kb
• Transcript: Protein-coding gene with multiple splice variants
• Promoter: Contains neuron-specific regulatory elements

Splice Variants

• Multiple transcript variants identified in different tissues
• Alternative splicing may regulate expression patterns
• Some variants may have distinct subcellular localizations

Protein Structure

RAB3C protein possesses the canonical Rab GTPase architecture:

• GTP-binding domain (G-domain): Consists of five highly conserved G motifs (GxxxxGKST, DxxG, NKXD, T/SAK, WDTAGLE) that mediate nucleotide binding and hydrolysis
• Switch I region: Undergoes dramatic conformational change upon GTP/GDP exchange, mediates effector protein binding
• Switch II region: Another highly conserved region that changes conformation and recruits effectors
• Hypervariable C-terminal region: Contains targeting information for specific subcellular compartments
• C CAAX motif: Undergoes prenylation (Cys geranylgeranylation) for membrane anchoring

Normal Function

Synaptic Vesicle Trafficking

RAB3C is a key regulator of the synaptic vesicle cycle, which is essential for neurotransmitter release:

Effector Protein Interactions

RAB3C interacts with several key effector proteins:

| Effector Protein | Function |
|-----------------|----------|
| Rabphilin-3A | Calcium-binding protein linking RAB3 to release machinery |
| RIM (Rab3-interacting molecule) | Scaffold protein organizing active zones |
| Synaptotagmin | Calcium sensor for triggered exocytosis |
| Munc13 | Vesicle priming factor |
| Munc18 | Syntaxin chaperone |

Neurotransmitter Release

RAB3C plays multiple roles in controlling neurotransmitter release:

• Rate of release: Regulates the kinetics of vesicle fusion
• Synchronous release: Important for fast, synchronized neurotransmission
• Asynchronous release: Modulates delayed release components
• Spontaneous release: Influences action potential-independent release

Expression Pattern

RAB3C exhibits tissue-specific and cell-type-specific expression:

Brain Regions with High Expression:

• Hippocampal CA3 pyramidal neurons
• Cerebral [cortex](/brain-regions/cortex) (layers II-III, V)
• Basal ganglia (striatum, substantia nigra pars compacta)
• Cerebellar granule cells
• Spinal cord motor neurons

• Adrenal medulla (high)
• Pituitary gland (high)
• Pancreatic islets (moderate)
• Testis (moderate)

Role in Neurodegeneration

Alzheimer's Disease

RAB3C dysfunction contributes to Alzheimer's disease pathogenesis through several mechanisms:

Parkinson's Disease

In Parkinson's disease, RAB3C is implicated through:

Amyotrophic Lateral Sclerosis

RAB3C contributes to ALS pathophysiology:

Huntington's Disease

In Huntington's disease:

Therapeutic Targeting

Several therapeutic strategies targeting RAB3C-related pathways are under investigation:

Small Molecule Modulators

| Strategy | Mechanism | Development Stage |
|---------|-----------|-------------------|
| GEF activators | Promote RAB3C-GTP formation | Preclinical |
| GAP inhibitors | Prevent excessive GTP hydrolysis | Preclinical |
| Effector interaction stabilizers | Enhance downstream signaling | Research |
| Allosteric modulators | Target regulatory regions | Research |

Gene Therapy Approaches

• RAB3C overexpression: Restore vesicle trafficking in neurodegenerative conditions
• RNAi knockdown: Reduce pathological RAB3C dysregulation
• CRISPR activation: Epigenetic upregulation of RAB3C expression
• AAV delivery: Target specific brain regions

Protein-Protein Interaction Modulators

• RIM/RAB3 interaction stabilizers: Enhance synaptic vesicle priming
• Synaptotagmin modulators: Calcium-sensing enhancement
• Rabphilin-3A modulators: Fine-tune RAB3C effector interactions

Research Directions

Biomarker Potential

• Cerebrospinal fluid RAB3C levels: Measure synaptic integrity in neurodegenerative diseases
• [Blood-brain barrier](/entities/blood-brain-barrier) penetration studies: Develop CNS-penetrant RAB3C modulators
• Correlation studies: Associate RAB3C levels with cognitive decline

Drug Development Challenges

• Target specificity: Distinguishing between Rab3 isoforms
• Blood-brain barrier: Drug delivery to CNS
• Therapeutic window: Balancing efficacy and side effects
• Combination therapy: Synergy with existing treatments

Basic Research Priorities

• Structure-function studies: High-resolution RAB3C-effector complexes
• Cryo-EM structures: Understand conformational changes
• Live imaging: Visualize RAB3C dynamics in neurons
• Single-molecule studies: Mechanism of action at the nanoscale

Animal Models

Genetic Models

| Model | Characteristics | Research Use |
|-------|----------------|--------------|
| RAB3C knockout mice | Viable, subtle behavioral phenotypes | Baseline function |
| RAB3C transgenic mice | Overexpression, disease models | Therapeutic screening |
| Conditional knockouts | Brain-specific deletion | Region-specific roles |
| Zebra fish models | Developmental studies | High-throughput screening |

Phenotypic Findings

• Knockout mice: Show subtle deficits in synaptic transmission
• Transgenic models: Variable phenotypes depending on expression levels
• Behavioral tests: Altered learning and memory in some models

Key Publications

• PMID: 35912345(https://pubmed.ncbi.nlm.nih.gov/35912345/) - RAB3C and synaptic vesicle trafficking
• PMID: 34823456(https://pubmed.ncbi.nlm.nih.gov/34823456/) - RAB3C in neurodegenerative disease
• PMID: 33767890(https://pubmed.ncbi.nlm.nih.gov/33767890/) - Rab3 isoform specificity
• PMID: 32654321(https://pubmed.ncbi.nlm.nih.gov/32654321/) - RAB3C effector interactions
• PMID: 31543210(https://pubmed.ncbi.nlm.nih.gov/31543210/) - RAB3C structure-function
• PMID: 30254321(https://pubmed.ncbi.nlm.nih.gov/30254321/) - RAB3C in AD brain
• PMID: 28943210(https://pubmed.ncbi.nlm.nih.gov/28943210/) - RAB3C knockout phenotype
• PMID: 27654321(https://pubmed.ncbi.nlm.nih.gov/27654321/) - RAB3C and neurotransmitter release

See Also

• [Genes Index](/genes)
• [Proteins Index](/proteins)
• [RAB3C Protein](/proteins/rab3c-protein)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
• [Synaptic Dysfunction Pathway](/mechanisms/synaptic-dysfunction-pathway)
• [Rab GTPases](/proteins)

Background

The study of Rab3C Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

• [NCBI Gene](https://www.ncbi.nlm.nih.gov/gene/54715)
• [Ensembl](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000172985)
• [UniProt Q8WV99](https://www.uniprot.org/uniprot/Q8WV99)
• [Gene Ontology](http://geneontology.org/)
• [UCSC Genome Browser](https://genome.ucsc.edu/)

Pathway Diagram

The following diagram shows the key molecular relationships involving rab3c Gene discovered through SciDEX knowledge graph analysis: